TRIENTINE-REDDY'S trientine dihydrochloride 250 mg capsule bottle

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

trientine dihydrochloride

Available from:

Dr Reddys Laboratories Australia Pty Ltd

Pharmaceutical form:

Capsule

Composition:

Excipient Ingredients: iron oxide yellow; titanium dioxide; Gelatin; magnesium stearate; purified water; macrogol 3350; colloidal anhydrous silica

Administration route:

Oral

Units in package:

100

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Trientine dihydrochloride capsules are indicated for the treatment of patients with Wilson's disease who are intolerant of penicillamine.

Product summary:

Visual Identification: Yellow opaque, hard gelatin size 1 capsules imprinted with RDY on cap and 459 on body in black ink filled with white to pale yellow powder.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Authorization status:

Registered

Authorization date:

2021-03-29